Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
Jess Inskip, Director of Investor Research at StockBrokers.com, breaks down Q2, the AI trade, Fed policy, earnings, and where investors should look next.
Quantum computing is moving from science fiction to national strategy. Infleqtion CEO Matt Kinsella explains Trump's new executive order and what it means.
Americans traveled in record numbers over July 4th despite rising costs. Skift's Sarah Kopit explains what it says about consumers, airfares, and summer travel.
The U.S. economy is being held up in part by the AI boom, but that boom could still lead to broader prosperity or inequality, says a Nobel Prize winner.
Foundation Robotics co-founder Michael LeBlanc explains how humanoid robots are moving from the lab to military and industrial missions and what comes next.
Jeff Burnstein, President of the Association for Advancing Automation (A3), discusses humanoid robots, AI, smart manufacturing, and the future of U.S. industry.
Should kids be banned from social media? Nick Lichtenberg of Fortune breaks down the global push to restrict under-16 users and what it means for Big Tech.
